Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in ACS Patients

NCT07064109 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

380

Enrollment

OTHER

Sponsor class

Conditions

ACS - Acute Coronary Syndrome

Interventions

DRUG: Colchicine 0.5 MG Oral Tablet Once Daily

Sponsor

Shanghai Tongji Hospital, Tongji University School of Medicine